Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript

Imunon, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.59. Imunon, Inc.

Related Keywords

New Jersey , United States , Alabama , Boston , Massachusetts , Texas , Oklahoma , Israel , Brookline , Pennsylvania , Philadelphia , Jeff Church , Sloan Kettering , Kim Golodetz , Michael Tardugno , David Bautz , Laura Suriel , Kemp Dolliver , Johns Hopkins , James Molloy , Corinne Le Goff , Le Goff , Oklahoma University , It Dm Clinical Research , Imunon Inc , Silicon Valley Bank , Exchange Commission , Alliance Global Partners , Hudson Technology Finance Corporation , Jeffrey Church , University Of Texas Md Anderson Cancer Center , Hudsonalpha Institute In Huntsville , Breakthrough Cancer Foundation , Nasdaq , Dm Clinical Research , Call Transcript March , Results Conference , Chief Financial Officer , Sebastien Hazard , Chief Medical , Kursheed Anwer , Chief Science Officer , Hudsonalpha Institute , Beth Israel , Memorial Sloan Kettering , Silicon Valley , Hudson Technology Finance , Obese Countries , Alliance Global , Anwer Kursheed , Brookline Capital , Targeted Product Profile ,